肿瘤研究与临床
腫瘤研究與臨床
종류연구여림상
CANCER RESEARCH AND CLINIC
2010年
12期
810-813
,共4页
金春晖%黄德芳%谭成%朱晓明%费亚军
金春暉%黃德芳%譚成%硃曉明%費亞軍
금춘휘%황덕방%담성%주효명%비아군
糖尿病,2型%结直肠癌%血管内皮生长因子%胰岛素样生长因子-1%小鼠
糖尿病,2型%結直腸癌%血管內皮生長因子%胰島素樣生長因子-1%小鼠
당뇨병,2형%결직장암%혈관내피생장인자%이도소양생장인자-1%소서
Diabetes Mellitus,type 2%Colorectal cancer%Vascular endothelial growth factor%Insulin-like growth factor-1%Mouse
目的 观察小鼠肠癌移植瘤在高血糖下的生长并检测瘤体血管内皮生长因子(VEGF)表达以及血清胰岛素样生长因子-1(IGF-1)的变化情况,探讨2型糖尿病(T2DM)是否为促进结直肠癌发生与进展的危险因素.方法 建立肠癌移植瘤合并T2DM的小鼠模型,观察移植瘤体积大小变化,5周末处死小鼠检测血清IGF-1及瘤体组织VEGF表达.结果 肠癌糖尿病组小鼠瘤体体积[(1628.5±882)mm3]大于肠癌组小鼠瘤体体积[(1950.2±726)mm3](P<0.05),其血清IGF-1[(105.33±32.32)ng/ml]高于正常组[(69.83±25.57)ng/ml]及肠癌组小鼠[(70.17±25.27)ng/ml](P<0.05),瘤体组织VEGF表达[(70.0±11.5)%]高于肠癌组[(42.9±7.5)%](P<0.05).结论 T2DM可能为促进肠癌生长的原因之一,其可能机制与血液中升高的IGF-1作用有关,并通过诱导VEGF基因转录,上调VEGF的表达,促使肿瘤组织血管生成,从而导致肿瘤的发生和转移.
目的 觀察小鼠腸癌移植瘤在高血糖下的生長併檢測瘤體血管內皮生長因子(VEGF)錶達以及血清胰島素樣生長因子-1(IGF-1)的變化情況,探討2型糖尿病(T2DM)是否為促進結直腸癌髮生與進展的危險因素.方法 建立腸癌移植瘤閤併T2DM的小鼠模型,觀察移植瘤體積大小變化,5週末處死小鼠檢測血清IGF-1及瘤體組織VEGF錶達.結果 腸癌糖尿病組小鼠瘤體體積[(1628.5±882)mm3]大于腸癌組小鼠瘤體體積[(1950.2±726)mm3](P<0.05),其血清IGF-1[(105.33±32.32)ng/ml]高于正常組[(69.83±25.57)ng/ml]及腸癌組小鼠[(70.17±25.27)ng/ml](P<0.05),瘤體組織VEGF錶達[(70.0±11.5)%]高于腸癌組[(42.9±7.5)%](P<0.05).結論 T2DM可能為促進腸癌生長的原因之一,其可能機製與血液中升高的IGF-1作用有關,併通過誘導VEGF基因轉錄,上調VEGF的錶達,促使腫瘤組織血管生成,從而導緻腫瘤的髮生和轉移.
목적 관찰소서장암이식류재고혈당하적생장병검측류체혈관내피생장인자(VEGF)표체이급혈청이도소양생장인자-1(IGF-1)적변화정황,탐토2형당뇨병(T2DM)시부위촉진결직장암발생여진전적위험인소.방법 건립장암이식류합병T2DM적소서모형,관찰이식류체적대소변화,5주말처사소서검측혈청IGF-1급류체조직VEGF표체.결과 장암당뇨병조소서류체체적[(1628.5±882)mm3]대우장암조소서류체체적[(1950.2±726)mm3](P<0.05),기혈청IGF-1[(105.33±32.32)ng/ml]고우정상조[(69.83±25.57)ng/ml]급장암조소서[(70.17±25.27)ng/ml](P<0.05),류체조직VEGF표체[(70.0±11.5)%]고우장암조[(42.9±7.5)%](P<0.05).결론 T2DM가능위촉진장암생장적원인지일,기가능궤제여혈액중승고적IGF-1작용유관,병통과유도VEGF기인전록,상조VEGF적표체,촉사종류조직혈관생성,종이도치종류적발생화전이.
Objective To observe colorectal tumor's growth in hyperglycemia mice and its vascular endothelial growth factor (VEGF)'s expression, insulin-like growth factor-1 (IGF-1)'s variation of blood through the experiment, then to ascertain whether type 2 diabetes mellitus (T2DM) danger factors to promote colorectal cancer happen and progress or not. Methods The mouse model of colorectal cancer combined T2DM was established. The volume of tumor was observed. After 5 weeks, all mice were executed and IGF-1 in the blood and the expression of VEGF in the tumor tissue was examined. Results The average tumor volume of colorectal tumor-diabetes group [(1628.5±882) mm3] were larger than that of colorectal tumor group [(1950.2±726) mm3] (P <0.05), and its expression IGF-1 of blood [(105.33±32.32) ng/ml] were higher than that of the control group [(69.83±25.57) ng/ml] and colorectal tumor group [(70.17±25.27) ng/ml] (P <0.05). The expression of VEGF [(70.0±11.5)%] in colorectal tumor-diabetes group were significantly higher than that of colorectal tumor group [(42.9±7.5)%] (P <0.05), too. Conclusion The model of T2DM and transplanted colorectal tumor can be duplicated successfully in ICR mice. Diabetes mellitus may be one reason of promoting colorectal cancer progress. Besides high blood glucose, its mechanism is the high level of IGF-1 which can inhibit apoptosis, promote cell differentiation and hyperplasia, and through inducing VEGF duplicating, heighten its expression, promote the tumor vessel growth, lead to tumor happen and metastasis.